Evidence map›Paper›PMID 9008714›Full record

ArticleThe Journal of cell biology1997

Bcl-2 lies downstream of parathyroid hormone-related peptide in a signaling pathway that regulates chondrocyte maturation during skeletal development.

M Amling, L Neff, S Tanaka, D Inoue, K Kuida, E Weir, W M Philbrick, A E Broadus, R Baron

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
12.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it, 307 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Profiling microRNA expression during fracture healing.BMC musculoskeletal disorders · 2016
    Article
  15. Article
  16. Article
  17. Genetic alterations in chondrosarcomas - keys to targeted therapies?Cellular oncology (Dordrecht, Netherlands) · 2014
    Review
  18. Cartilage to bone transitions in health and disease.The Journal of endocrinology · 2013
    Review
  19. Article
  20. Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

M AmlingDepartment of Cell Biology, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
L Neff
S Tanaka
D Inoue
K Kuida
E Weir
W M Philbrick
A E Broadus
R Baron
Tokyo Metropolitan Institute of Medical Science · JPUniversität Hamburg · DEYale University · US

Funding

Regulation of Osteoclastic Bone Resorption:Role of Cb1bR01DE004724 · NIDCR · YALE UNIVERSITY · PI BARON, ROLAND E · 1985 to 2008
$2.0M
REGULATION OF OSTEOCLASTIC BONE RESORPTIONR37DE004724 · NIDCR · YALE UNIVERSITY · PI BARON, ROLAND E · 1993 to 2002
$998k
PARATHYROID HORMONE-RELATED PEPTIDER37AR030102 · NIAMS · YALE UNIVERSITY · PI BROADUS, ARTHUR EASTWOOD · 1992 to 2001
$818k
MALIGNANCY-ASSOCIATED HYPERCALCEMIAR01AR030102 · NIAMS · YALE UNIVERSITY · PI BROADUS, ARTHUR EASTWOOD · 1986 to 1991
–
NIAMS NIH HHS AR-30102NIAMS NIH HHS R37 AR030102NIDCR NIH HHS DE-04724NIDCR NIH HHS R01 DE004724NIDCR NIH HHS R37 DE004724
6 · The paper itself

Abstract

Parathyroid hormone-related peptide (PTHrP) appears to play a major role in skeletal development. Targeted disruption of the PTHrP gene in mice causes skeletal dysplasia with accelerated chondrocyte maturation (Amizuka, N., H. Warshawsky, J.E. Henderson, D. Goltzman, and A.C. Karaplis. 1994. J. Cell Biol. 126:1611-1623; Karaplis, A.C., A. Luz, J. Glowacki, R.T. Bronson, V.L.J. Tybulewicz, H.M. Kronenberg, and R.C. Mulligan. 1994. Genes Dev. 8: 277-289). A constitutively active mutant PTH/PTHrP receptor has been found in Jansen-type human metaphyseal chondrodysplasia, a disease characterized by delayed skeletal maturation (Schipani, E., K. Kruse, and H. Jüppner. 1995. Science (Wash. DC). 268:98-100). The molecular mechanisms by which PTHrP affects this developmental program remain, however, poorly understood. We report here that PTHrP increases the expression of Bcl-2, a protein that controls programmed cell death in several cell types, in growth plate chondrocytes both in vitro and in vivo, leading to delays in their maturation towards hypertrophy and apoptotic cell death. Consequently, overexpression of PTHrP under the control of the collagen II promoter in transgenic mice resulted in marked delays in skeletal development. As anticipated from these results, deletion of the gene encoding Bcl-2 leads to accelerated maturation of chondrocytes and shortening of long bones. Thus, Bcl-2 lies downstream of PTHrP in a pathway that controls chondrocyte maturation and skeletal development.

Indexed as

AnimalsApoptosisbcl-2-Associated X ProteinBone DevelopmentCartilageCells, CulturedCollagenGene ExpressionGrowth PlateHumansHypertrophyMiceMice, KnockoutMice, TransgenicOrgan SpecificityParathyroid Hormone-Related Proteinbcl-2-Associated X ProteinCollagenParathyroid Hormone-Related ProteinProteinsProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2PTHLH protein, humanRecombinant Fusion Proteins

Identifiers

PMID9008714
PMCPMC2132464
OpenAlexW2170335058

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.